Pain-relieving drug NGX426 safe and well tolerated in Phase I trial.
- Published in:
- Expert Review of Neurotherapeutics, 2009, v. 9, n. 4, p. 436
- Publication type:
- Article
Works matching DE "TORREYPINES Therapeutics Inc."
Results: 4
1
2
Pain-relieving drug NGX426 safe and well tolerated in Phase I clinical trial.
- Published in:
- Expert Review of Anti-infective Therapy, 2009, v. 7, n. 3, p. 257
- Publication type:
- Article
3
CLINICAL TRIALS NEWS.
- Published in:
- Applied Clinical Trials, 2007, v. 16, n. 4, p. 18
- Publication type:
- Article
4
Newsbriefs.
- Published in:
- American Journal of Alzheimer's Disease & Other Dementias, 2005, v. 20, n. 5, p. 264, doi. 10.1177/153331750502000507
- Publication type:
- Article